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ABSTRACT 
This study aimed to investigate the antidiabetic effect of methanolic extract of Aphanamixis polystachya leaves in streptozotocin (STZ) induced 
diabetic rats. Wistar rats in each were divided into six groups and these animals were used for the study. In our study methanolic extract of 
Aphanamixis polystachya leaves was screened for antidiabetic activity in streptozotocin (STZ)-induced diabetic rats. The anti-diabetic activity 
was assessed using blood glucose level, body weight and various biochemical parameters like serum total cholesterol level (TC), triglyceride 
(TG) level, high-density lipoproteins (HDL), total protein (TP), serum alanine transaminase (SGPT) and aspartate aminotransferase (SGOT), 
respectively. The methanolic extract of Aphanamixis polystachya leaves exhibited an antidiabetic effect by significantly decreased the level of 
blood glucose, body weight, TC, TG, TP and increase HDL. The results of the study demonstrated that the treatment with methanolic extract of 
Aphanamixis polystachya leaves significantly (P<0.05) and dose-dependently prevented STZ-induced diabetic rats. The antioxidant property of 
plant phenolic and flavonoid contents present in methanolic extract of Aphanamixis polystachya leaves might be responsible for the antidiabetic 
activity. 
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Diabetes mellitus (DM) is considered as an important health 
confounder in our world, which necessitates its better 
management by new methods. DM consists of a number of 
endocrine impairments, which are mostly associated with 
uncontrolled blood glucose levels. Pancreatic damage may be 
due to inflammatory processes such as pancreatitis, or may 
be induced mainly by autoimmune diseases, drugs or toxins, 
infections, starvation, low protein diet and high fat diet. In 
order to perform the studies over DM, several animal models 
were designed. Among them, Streptozotocin (STZ) induced 
diabetes can be named as one of the most popular. STZ is a 
compound which has preferable toxicity for pancreatic beta 
cells1. DM consists of a group of syndromes characterized by 
hyperglycemia, altered metabolism of lipids, carbohydrates, 
and proteins, and an increased risk of complications from 
vascular disease2. Apart from currently available therapeutic 
options for diabetes like oral hypoglycemic agents and 
insulin, which have limitations of their own, many herbal 
medicines have been recommended for the treatment of 
diabetes3. A variety of ingredients present in medicinal 
plants are thought to act on a variety of targets by various 
modes and mechanisms. They have the potential to impart 
therapeutic effect in complicated4. 
Aphanamixis polystachya is widely used in analgesic, CNS 
depressant activity, cytotoxicity, antimicrobial activity, anti-
hepatotoxic activity and antioxidant. The present study was 
undertaken to evaluate the antidiabetic effect of methanolic 
extract of Aphanamixis polystachya leaves in streptozotocin 
(STZ) induced diabetic rats. 
MATERIALS AND METHOD   
Experimental 
The A. polystachya methanolic extracts obtained was 
subjected to the preliminary phytochemical analysis 
following standard methods. The extract was screened to 
identify the presence or absence of various active principles 
like phenolic compounds, carbohydrates, flavonoids, 
glycosides, saponins, alkaloids, fats or fixed oils, protein and 
amino acid and tannins. 
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Animals   
Wistar rats (150–200 g) were group housed (n= 6) under a 
standard 12 h light/dark cycle and controlled conditions of 
temperature and humidity (25±2 °C, 55–65%). Rats received 
standard rodent chow and water ad libitum. Rats were 
acclimatized to laboratory conditions for 7 days before 
carrying out the experiments. All the experiments were 
carried in a noise-free room between 08.00 to 15.00 h. 
Separate group (n=6) of rats was used for each set of 
experiments. The animal studies were approved by the 
Institutional Animal Ethics Committee (IAEC), constituted for 
the purpose of control and supervision of experimental 
animals by Ministry of Environment and Forests, 
Government of India, New Delhi, India. 
Toxicity Study 
In this study, acute toxicity study was carried according to 
Organization for Economic Cooperation and Development, 
guideline 423.Alimit dose of 2,000 mg/ kg body weight/oral 
was used. The signs of toxic effects and/or mortality were 
observed 3 h after administration 
then for the next 48 h. The body weight was recorded for 
consecutive 14 days. Since the both extracts were found safe 
up to the dose level of 2,000 mg/kg body weight, a dose of 
100 and 
200 mg/kg body weight of the two extracts was selected for 
screening of the antidiabetic activity. 
Induction of Experimental Diabetes in Rats 
Streptozotocin was dissolved in 100 mM citrate buffer (pH 
4.5) and calculated amount of the dose (60 mg/kg) of the 
fresh solution was injected intraperitoneally to overnight 
fasted rats. Blood glucose was checked 48 h later and 
animals showing blood glucose value more than 250 mg/dl 
were included in the experiments and termed as diabetic1.  
Experimental Protocol 
Animals were divided into five groups of 6 rats each. 
Group I: Rats served as normal-control and received the 
vehicle (0.5 ml distilled water/day/rat) 
Group II: Rats served as diabetic-control and received the 
vehicle (0.5 ml distilled water/day/rat) 
Group III: Rats (diabetic) were administered Glibenclamide 
(600µg/kg p.o.) for 21 days. 
Group IV: Rats (diabetic) were administered methanolic 
extract of Aphanamixis polystachya leaves (100 mg/kg p.o.) 
for 21 days. 
Group V: Rats (diabetic) were administered methanolic 
extract of Aphanamixis polystachya leaves (200 mg/kg p.o.) 
for 21 days. 
Biochemical Evaluation in Serum  
Serum total cholesterol level (TC), triglyceride (TG) level, 
high-density lipoproteins (HDL), total protein (TP), serum 
alanine transaminase (SGPT) and aspartate 
aminotransferase  (SGOT) was determined by using standard 
kits from Transasia BioMedical Limited, Mumbai, India. The 
estimation procedure is obtained in detail from leaflets 
provided by the commercially available kits are as follows. 
Statistical Analysis 
The statistical significance was assessed using one-way 
analysis of variance (ANOVA) followed by Tukey’s post hoc 
test. The values were expressed as mean ± SD and P<0.05 
was considered significant.  
RESULTS  
Phytochemical screening 
The results of qualitative phytochemical analysis of the crude 
powder of leaves, stems and root bark of A. polystachya. 
Methanolic leaves of A. polystachya showed the presence of 
alkaloids, glycosides, flavonoids, saponins, phenols, proteins 
and amino acids and carbohydrate. 
Antidiabetic activity 
Blood glucose level of animals in all groups was recorded at 
0,8th and 21th day and change in % blood glucose was also 
mentioned as shown in Table 2. Progressive decrease in 
blood glucose level was found in all treatment groups during 
study. At the end of experiment, all treatment groups, with 
100 mg/kg and 200 mg/kg of methanolic extract of 
Aphanamixis polystachya leaves was  decrease significantly (p 
< 0.001) serum glucose level, as represented in Table 1.
 
Table 1: Antidiabetic effect of Aphanamixis polystachya extract on blood glucose (mg/dl) in in STZ induced diabetic 
rats 
Groups Treatment Blood glucose (mg/dl) 
Days 0                           Days 8                               Days 21 
I Normal 71.00 ± 3.60                 90.00 ± 5.00                   109.10 ± 7.42 
II Diabetic Control 293.00 ± 7.70            390.00 ± 10.00#                             408.15± 11.10# 
III Diabetic +  Glibenclamide (600µg/kg) 260.10± 7.40             132.80 ± 7.00*                   120.00 ± 6.20* 
IV Diabetic + Aphanamixis polystachya leaves 
(100 mg/kg) 
270.00 ± 6.78             162.00± 8.10                          132.15 ± 7.10* 
V Diabetic + Aphanamixis polystachya leaves 
(200 mg/kg) 
      246.00 ± 5.00             142.00 ± 3.10*                        118.34± 4.80* 
Values are expressed as mean±S.E.M. (n = 6).Values are statistically significant at # P<0.01 vs. normal group;**P<0.01, *P<0.05 
vs. diabetes control group respectively (One-way ANOVA followed by Tukey’s post hoc test). 
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Body weight of animals in all groups was recorded at initial 
and final day weight was mentioned. In all treatment groups, 
with 100 mg/kg and 200 mg/kg of methanolic extract of 
Aphanamixis polystachya leaves was not significant in body 
weight during study period as represented in Table 2. 
 
Table 2: Antidiabetic effect of methanolic extract of Aphanamixis polystachya leaves on body weight in STZ induced 
diabetic rats. 
Groups Treatment Initial weight (g) Final weight (g) 
I Normal 200.00 ± 9.90 208.00 ± 11.18 
II Diabetic Control 198.00 ± 9.70 188.00 ± 9.64 
III Diabetic +  Glibenclamide (600µg/kg) 198.60 ± 9.90 216.00 ± 10.98* 
IV Diabetic + Aphanamixis polystachya leaves (100 mg/kg) 194.00 ± 9.75 192 .00 ± 6.00* 
V Diabetic + Aphanamixis polystachya leaves (200 mg/kg) 193.10 ± 9.59 206.00 ± 09.90* 
Values are expressed as mean±S.E.M. (n = 6).Values are statistically significant at # P<0.01 vs. normal group;**P<0.01, *P<0.05 
vs. diabetes control group respectively (One-way ANOVA followed by Tukey’s post hoc test). 
 
The effect of methanolic extract of Aphanamixis polystachya 
leaves on lipid profile of diabetic rats is displayed in Table 3. 
In diabetic rats, the levels of triglycerides (TG), total 
cholesterol (TC) and low density lipoprotein (LDL) were 
significantly increased and high density lipoprotein (HDL) 
level was significantly decreased. In methanolic extract of 
Aphanamixis polystachya leaves (100 and 200 mg/kg) 
treated groups, the TG, TC and LDL levels activities were 
significantly decreased and high density lipoprotein (HDL) 
level was significantly increased. 
 
Table 3: Antidiabetic effect of methanolic extract of Aphanamixis polystachya leaves on serum lipid profile in STZ 
induced diabetic rats 








I Normal 81.50 ± 6.50 79.00 ± 8.90 60.18±2.00 90.90±6.70 
II Diabetic Control 194.50 ± 6.70 142.5 ± 7.50 30.20±2.10 191.30±6.50 
III Diabetic +  Glibenclamide (600µg/kg) 118.00 ± 5.95*** 81.00 ± 9.30** 57.60±2.55*** 93.60±5.61*** 
IV Diabetic + Aphanamixis polystachya 
leaves (100 mg/kg) 
130.00 ± 6.10** 85.10 ± 6.60* 
 55.00±2.10** 119.20±7.10** 
V Diabetic + Aphanamixis polystachya 
leaves (200 mg/kg) 
121.00 ± 6.00*** 83.20 ± 6.00* 
56.20±2.16*** 100.30±6.50*** 
Values are expressed as mean±S.E.M. (n = 6).Values are statistically significant at # P<0.01 vs. normal group;**P<0.001, *P<0.05 
vs. diabetes control group respectively (One-way ANOVA followed by Tukey’s post hoc test). 
 
There was a significant increase in activities of SGOT and 
SGPT in diabetic rats. After treatment with methanolic 
extract of Aphanamixis polystachya leaves (100 and 200 
mg/kg) the activities of SGOT and SGPT activities were 
significantly (p < 0.05) reduced as compared to diabetic 
control rats. A significant decrease in serum total protein 
(TP) level was observed in diabetic rats. After treatment 
with methanolic extract of Aphanamixis polystachya leaves 
(100 and 200 mg/kg) for 21 days the TP level was 
significantly compared to diabetic control rats. 
Glibenclamide (600µg/kg) treated rats also showed 
significant effects on blood levels of SGOT, SGPT, SALP and 
TP in diabetic rats (Table 4). 
 
Table 4: Antidiabetic effect of methanolic extract of Aphanamixis polystachya leaves on SGOT and SGPT in STZ induced 
diabetic rats 
Group Treatment SGOT (IU/L) SGPT (IU/L) TP (g/dL) 
I Normal 50. 90±4.88 60.00±4.00 7.00 ± 2.0 
II Diabetic Control 138.47±4.00 130.66±6.30 7.60 ± 1.5 
III Diabetic +  Glibenclamide (600µg/kg) 59.50±4.20*** 68.90±4.95***   9.1 ± 2.0** 
IV Diabetic + Aphanamixis polystachya leaves (100 mg/kg) 86.88±4.10* 85.70±5.50**   10.0 ± 2.3** 
V Diabetic + Aphanamixis polystachya leaves (200 mg/kg) 77.79±3.90** 77.76±6.10**   9.9 ± 1.8** 
Values are expressed as mean±S.E.M. (n = 6).Values are statistically significant at # P<0.01 vs. normal group; **P<0.01, *P<0.05 
vs. diabetes control group respectively (One-way ANOVA followed by Tukey’s post hoc test) 
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DISCUSSION 
In accordance, findings from the current investigation 
showed that STZ administration (i.p) effectively induced 
diabetes mellitus in physiologically normal rats as reflected 
by hyperglycemia, pancreatic beta cells degeneration, 
decreased insulin and glycogen levels in diabetic control 
animals5. In contrast, Aphanamixis polystachya leaf extract 
at the administered doses (100 and 200 mg/kg BW) 
significantly lowered STZ-induced hyperglycemia, improved 
insulin and glycogen contents in extract-treated rats 
compared to diabetic control animals. The  above  finding  is  
in  agreement  with  previous  study  where  oral 
administration  of  extracts  significantly  reduces  blood  
glucose  in  STZ-induced  diabetes in  rats6. Improvement in 
oral glucose tolerance capacity is one of the several 
mechanisms by which diabetes is controlled and managed. 
In this study, the extract appeared to have significantly 
suppressed the degree of hyperglycemia induced by glucose 
loading in treated rats compared to control animals. This 
connotes that Aphanamixis polystachya extract may be 
capable of providing some degree of delay in the onset of 
diabetes. Improved glucose tolerance is associated with the 
availability and functionality of plasma insulin. This is 
evident in the present study in which treatment of rats with 
the extract significantly improved the level of insulin both in 
the serum and pancreas. This is may have arguably play a 
critical role in the hypoglycemic ability exhibited by the 
extract in lowering STZ-induced hyperglycemia in the 
treated animals relative to the diabetic control animals. The 
observed increase in both serum and pancreatic insulin 
concentrations is obviously connected to the ability of the 
extract to protect the animals against STZ- induced beta cell 
degeneration, and consequent activation of insulin 
production and release5. 
In the present study, all treatment groups, with 100 mg/kg 
and 200 mg/kg of methanolic extract of Aphanamixis 
polystachya leaves 100 mg/kg and 200 mg/kg was not 
significant in body weight during study period. The decrease 
in body weight in diabetic rats could be due to dehydration 
and catabolism of fats and proteins7.  
Hyperlipidemia is a recognized complication of diabetes 
mellitus, characterized by elevated levels of cholesterol, 
triglycerides, and phospholipids, as well as changes in 
lipoprotein composition. In the present study, serum 
triglycerides, cholesterol and LDL cholesterol were 
significantly elevated while HDL cholesterol was 
significantly decreased in diabetic rats. Interestingly, the 
results further indicated that all these lipid and lipoprotein 
abnormalities were countered by mulberry leaves in 
diabetic rats. The most characteristic lipid abnormality is 
hypertriglyceridemia with associated increase in plasma 
cholesterol. Elevated plasma triglyceride concentration is 
seen in type1 DM and type 2 DM either due to triglyceride 
over-production and /or underutilization. Lipoprotein lipase 
activity is markedly impaired, besides, a significant 
improvement in LDL internalization and degradation 
suggesting that chemical modification of LDL particle like 
nonenzymatic glycation of LDL itself might result in its 
increased incorporation in the arterial wall via a receptor 
independent pathway. Previous studies have demonstrated 
that multidirectional lipid-lowering effects on the rat 
metabonome, including limitation of the absorption of 
cholesterol, inactivation of HMG-CoA, and favorable 
regulation of profiles of essential polyunsaturated fatty acid. 
In diabetes, hyperglycemia is accompanied with 
dyslipidemia characterized by increase in TC, LDL and TG 
and fall in HDL8. A dose of 100 mg/kg and 200 mg/kg of 
methanolic extract of Aphanamixis polystachya leaves was 
significantly decreased TC, TG, LDL level and increased HDL 
level as compare to control group. The present study in line 
with Komeili et al.9 which revealed that the hydroalcoholic 
extract for 4 weeks significantly decreased the levels of 
glucose, triglyceride, cholesterol, and LDL-c and increased 
the level of HDL-c in diabetic rats. In the present study, the 
significant increase in serum SGOT and SGPT levels that was 
observed in STZ-induced diabetic rats represents liver 
damage compared to control rats. Liver necrosis in STZ-
induced diabetic rats increased the activities of SGPT and 
SGOT in plasma by leakage of these enzymes from liver 
cytosol into the blood stream. Oral administration of 
Aphanamixis polystachya showed its protective nature on 
liver tissue by reducing the elevated levels of SGOT and 
SGPT10. In this study, a dose of 100 mg/kg and 200 mg/kg of 
methanolic extract of Aphanamixis polystachya leaves was 
significantly (p < 0.05) normalized the content of protein 
total protein. Kondeti et al have reported that STZ induced 
diabetic rats account for the observed decrease in the total 
protein content. Increased urea production in diabetes might 
be due to enhanced catabolism of both liver and plasma 
proteins. The plant extract treatment has appreciably 
normalized the content of protein and urea11. The 
methanolic extract of Aphanamixis polystachya extracts 
have been chosen because of its expected flavonoid contents 
that were reported to have antidiabetic activity. The activity 
of phenolics having antioxidant activity further confirms this 
view. The phytochemical analysis of methanolic extract of 
Aphanamixis polystachya leaves showed the presence of 
tannins, flavonoids, saponins, and sterols. Their antidiabetic 
ability to regenerate the pancreatic β-cell has already been 
proved. Sterols can decrease blood sugar in experimental 
animal models. Our current investigation supports the 
traditional use of Aphanamixis polystachya in the treatment 
of diabetes. 
CONCLUSION  
As a conclusion, it could be speculated that the observed 
hypoglycemic and antioxidant activities of methanolic 
extract of Aphanamixis polystachya leaves might be related to 
the tannins, terpenoids, and flavonoids contents. The 
extracts significantly reduced fasting glucose levels in 
diabetic rats and also reduced the lipid profile parameters in 
diabetic rats. The extracts were found significantly 
decreasing the activities of SGPT and SGOT in diabetic rats 
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